Group 1 - The Hang Seng Index Company announced the quarterly review results for the Hang Seng Index series, effective from March 9, 2026, after market close on March 6, 2026 [1] - The Hang Seng Index will add three stocks: Contemporary Amperex Technology Co., Limited (03750), Luoyang Molybdenum Co., Ltd. (03993), and Laopuhuang Co., Ltd. (06181), while removing Zhongsheng Group Holdings Limited (00881), increasing the number of constituent stocks from 88 to 90 [1] - Laopuhuang has seen a significant price increase, with a cumulative rise of nearly 20% since the beginning of 2026 [1] Group 2 - The Hang Seng China Enterprises Index will maintain 50 constituent stocks, adding Beike-W (02423) and Horizon Robotics-W (09660), while removing China Resources Beer (00291) and Mengniu Dairy (02319) [2] - The Hang Seng Composite Index will add 53 stocks, including Bank of East Asia (00023), and remove 28 stocks, including Shui On Land (00272), increasing the number of constituent stocks from 507 to 532 [5] - The Hang Seng Technology Index will not change, maintaining 30 constituent stocks [6] Group 3 - The total assets under management for products tracking the Hang Seng Index series is approximately $117.7 billion as of December 2025 [6] - The adjustments in index constituents may trigger passive fund rebalancing, potentially leading to increased trading volume for related stocks as the effective date approaches [6] - The inclusion of new economy enterprises in sectors like renewable energy, new consumption, and biotechnology is expected to enhance the growth potential and investment attractiveness of the indices, reducing the weight of traditional industries [6]

Core Viewpoint - The article highlights the increasing trend of cornerstone investments in Hong Kong IPOs, indicating a strong interest from long-term capital, particularly in new economy enterprises, which is seen as a vote of confidence in the market's future potential [1][14]. Group 1: Cornerstone Investment Trends - Cornerstone investors are crucial in Hong Kong IPOs, committing to purchase large amounts of shares at the issue price and agreeing to lock up their shares for a certain period, typically at least six months [3]. - In 2025, 89 IPO companies are expected to introduce cornerstone investors, with total investments reaching approximately 1,066 billion HKD, marking a historical high [3][5]. - In January 2026, all 13 new IPOs in Hong Kong included cornerstone investors, with total investments amounting to 185.21 billion HKD, a significant increase of 13.3 times compared to the previous year [3][5]. Group 2: Investor Composition - The composition of cornerstone investors includes insurance funds, foreign institutions, and leading private equity firms, with notable participants such as Taikang Life, Temasek, BlackRock, and Morgan Stanley [1][7][8]. - Insurance funds have shown a marked increase in participation, with 15.58 billion HKD in cornerstone subscriptions across 10 IPOs this year, compared to 26.20 billion HKD across 12 IPOs in 2025 [7]. Group 3: Sector Preferences - Long-term capital, including insurance funds and sovereign wealth funds, tends to favor large IPOs and industry leaders, particularly in sectors like artificial intelligence, high-end manufacturing, semiconductors, and biomedicine [10][12]. - New economy leaders are particularly attractive to capital, with significant investments in companies like Zhiyuan, Biran Technology, and others, reflecting a strong interest in sectors aligned with national strategic directions [10][11]. Group 4: Market Dynamics - The active participation of long-term capital in cornerstone investments is viewed as a confidence vote in the ongoing economic transformation and upgrading in China [14]. - The Hong Kong market is becoming a vital window for global capital to allocate Chinese assets, with improved investment quality and market mechanisms attracting significant foreign investment [15].

Group 1 - The rumor regarding a "300 billion market cap threshold for Hong Kong IPOs" has been confirmed as unfounded by multiple investment banking professionals, indicating that such a limit is impractical given the current market conditions [1] - There are currently 337 companies in the IPO queue, many of which have market caps below 300 billion, suggesting that imposing such a threshold could hinder financing for small and medium enterprises and negatively impact industry growth [1] Group 2 - The current IPO landscape in Hong Kong is characterized by the difficulty of issuance despite easier approval processes, with increasing pressure on companies as the number of listings rises [2] - Companies that are likely to attract interest in the Hong Kong market fall into two categories: innovative firms in biotechnology and specialized technology sectors, and traditional industry leaders with strong performance and profitability [3] - Predictions indicate that the IPO market will continue to heat up through 2026, with a focus on new economy sectors like AI and biomedicine, although the challenges of issuance will persist [3]

Core Insights - The Hong Kong IPO market is expected to continue its growth trend in 2026, with fundraising projected to reach between HKD 320 billion to HKD 350 billion [1][2][3] Group 1: 2025 Performance - In 2025, Hong Kong regained its position as the global leader in IPO fundraising, achieving a total of HKD 285.8 billion, which is an increase of over 225% compared to 2024 [1][2] - A total of 119 IPOs were recorded in 2025, marking a 68% increase from the previous year [1] - The main sectors for IPOs included retail, consumer goods, and services (28%), followed by information technology and telecommunications (26%), and healthcare and pharmaceuticals (25%) [1] Group 2: Future Outlook - PwC anticipates that around 150 companies will successfully list in Hong Kong in 2026, with over 10 companies expected to raise more than HKD 5 billion each [2] - The trend of A-share companies seeking international fundraising through the Hong Kong capital market is expected to continue, with the number of H-share listings increasing from 30 in 2024 to 76 in 2025, a rise of 153% [2] - New economy companies, particularly those in innovation and biotechnology, are expected to be the focus of listings in 2026 [2][3] Group 3: Market Dynamics - The overall decline in interest rates is boosting investor confidence, while government policies are further supporting the market [1][2] - The diversity in the types of companies seeking to list is expected to provide innovative and technology-related funding opportunities, enhancing market depth [3] - The demand for international financing from Chinese enterprises remains strong, despite global geopolitical uncertainties [3]

Core Viewpoint - In 2025, the Hong Kong Stock Exchange (HKEX) is expected to lead the global IPO market with a projected fundraising total exceeding HKD 280 billion, marking a significant return to prominence after several years [1][2]. Group 1: IPO Market Dynamics - The HKEX is anticipated to host 117 new listings in 2025, averaging a new listing every two trading days [1]. - Major IPO projects are significantly contributing to the overall fundraising scale, with the top ten IPOs expected to account for a substantial portion of the total [3][4]. - Six of the top ten IPOs are "A+H" listed companies, collectively raising HKD 1,033.20 million, which represents 36.12% of the total IPO fundraising for the year [4]. Group 2: A-Share Influence - The "A-share" influence is increasing, with 19 A-share companies successfully listing in Hong Kong, raising a total of HKD 1,399.93 million, nearly half of the total new fundraising [6]. - The "A+H" listing model is becoming a preferred choice for many companies, driven by various strategic needs such as international expansion and risk diversification [6][8]. Group 3: Policy Support - Continuous policy support is fueling the IPO trend, including measures from the China Securities Regulatory Commission to encourage leading companies to list in Hong Kong [7][8]. - Recent optimizations to HKEX listing rules have made it easier for companies to meet public shareholding requirements, further lowering the barriers for listing [8]. Group 4: New Economic Forces - The IPO market is witnessing a strong emergence of "new economy" companies, particularly in sectors like AI and robotics, with six companies set to list simultaneously [10]. - The hard technology sector is a key driver, with significant representation in the IPO pipeline, including 20 companies in pharmaceuticals and 19 in software services [11]. Group 5: Consumer Brands - The "new consumption" sector is also thriving, with 19 companies from various consumer industries listing in 2025, many of which had previously attempted to list in the A-share market [13][14]. - High demand for these consumer brands is evident, with many experiencing subscription rates exceeding 100 times, indicating strong investor interest [13][14]. Group 6: Market Performance and Future Outlook - The IPO market is showing a notable improvement in profitability, with a record low IPO failure rate of 28.83% and significant first-day price increases for many new listings [16]. - Despite some recent volatility, forecasts for 2026 remain optimistic, with expectations of around 160 new listings and fundraising of at least HKD 300 billion [18]. - Long-term prospects suggest that the HKEX could solidify its role as a global pricing hub for Chinese assets, contingent on maintaining high-quality listings and robust capital flows [19].

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is experiencing a resurgence in IPO activity, with an expected total fundraising amount exceeding HKD 280 billion in 2025, reclaiming its position as the global leader in IPO fundraising [1][4]. Group 1: IPO Market Dynamics - In 2025, HKEX is projected to have 117 new listings, averaging one IPO every two trading days [1]. - The total IPO fundraising amount is expected to reach HKD 286.3 billion (approximately USD 36 billion), surpassing Nasdaq's annual expectations [4]. - Six companies listed on both A-share and H-share markets contributed significantly to the fundraising, totaling HKD 1,033.2 million, accounting for 36.12% of the total IPO fundraising [4]. Group 2: A+H Listing Trend - Nineteen A-share companies successfully listed on the HKEX in 2025, raising a total of HKD 1,399.93 million, which constitutes nearly half of the total new stock fundraising in the Hong Kong market [5]. - The A+H listing model is becoming increasingly popular among companies, driven by various strategic needs such as international expansion and risk hedging [6]. - Regulatory support, including relaxed public holding requirements for A+H issuers, has facilitated this trend [6]. Group 3: New Economy and Technology Focus - The IPO market in 2025 is characterized by a strong influx of new economy companies, particularly in sectors like AI and robotics, indicating a broad appeal for innovative businesses [9]. - The healthcare and software service sectors are leading in the number of IPOs, with significant growth observed in companies like Paig Bio and autonomous driving firms [9][10]. - The introduction of specific listing rules for biotech and specialized technology companies has resulted in 88 listings since their implementation, showcasing the effectiveness of these regulations [10]. Group 4: Market Performance and Investor Sentiment - The IPO market has seen a notable increase in profitability, with a first-day IPO failure rate of approximately 28.83%, the lowest in five years [14]. - A record net inflow of HKD 1.41 trillion from southbound funds was observed, marking a 74.37% increase from the previous year [14]. - Despite the positive trends, there are concerns about market capacity and the potential for increased volatility as new listings surge [14]. Group 5: Future Outlook - Forecasts for 2026 suggest continued vibrancy in the IPO market, with expectations of around 160 new listings and fundraising of at least HKD 300 billion [15]. - The long-term vision for the HKEX includes becoming a global pricing hub for core Chinese assets, necessitating ongoing regulatory improvements and enhanced cross-border capital flow [15][16]. - Strengthening the link between mainland and Hong Kong markets through initiatives like ETF connectivity is essential for reinforcing Hong Kong's role as a global financial center [16].

Core Viewpoint - In 2025, the Hong Kong Stock Exchange (HKEX) is expected to lead the global IPO market with a projected fundraising total exceeding 280 billion HKD, marking a significant comeback after several years [2][4]. Group 1: IPO Market Dynamics - The HKEX is anticipated to host 117 new listings in 2025, averaging a new listing every two trading days [2]. - The total IPO fundraising amount for 2025 is projected to reach 286.3 billion HKD (approximately 36 billion USD), surpassing Nasdaq's expectations [4]. - A notable trend is the increase in "A-share inclusion," with 19 A-share companies successfully listing in Hong Kong, contributing nearly half of the total new fundraising amount [7]. Group 2: Major Contributors to IPO Growth - Six major IPOs, including leading companies like CATL and Heng Rui Medicine, are expected to raise a combined total of 1,033.2 billion HKD, accounting for 36.12% of the total IPO fundraising [6]. - The "A+H" listing model is becoming increasingly popular among companies, serving various strategic needs such as international expansion and risk hedging [9]. Group 3: Policy Support and Market Structure - Continuous policy support, including measures from the China Securities Regulatory Commission to encourage leading companies to list in Hong Kong, is fueling this IPO trend [10][11]. - Recent optimizations to HKEX listing rules have made it easier for companies to meet public shareholding requirements, further enhancing the attractiveness of the Hong Kong market [12]. Group 4: Emerging Sectors and New Economy - The IPO market is witnessing a strong emergence of "new economy" companies, particularly in sectors like AI and robotics, with six companies set to list simultaneously [13]. - The hard technology sector is a significant contributor, with 20 biotech companies and 19 software service companies leading the number of new listings [14]. Group 5: Investment Sentiment and Market Performance - The IPO market's performance is reflected in a low first-day IPO failure rate of approximately 28.83%, the lowest in five years, with many new stocks seeing significant price increases [19]. - The net inflow of southbound funds into Hong Kong stocks reached a record 1.41 trillion HKD, a 74.37% increase from the previous year [19]. Group 6: Future Outlook - Forecasts suggest that in 2026, around 160 new stocks will list in Hong Kong, with fundraising expected to exceed 300 billion HKD, maintaining the market's leading position globally [20]. - Long-term prospects indicate that the Hong Kong market could become a global pricing hub for core Chinese assets, enhancing its attractiveness to international capital [21].

Core Viewpoint - The Hong Kong capital market is experiencing a strong recovery in 2025, with significant improvements in market capitalization, trading volume, and IPO activities compared to the previous year [1][3]. Market Capitalization - As of the end of November 2025, the total market capitalization of the securities market reached HKD 48.0 trillion, a 41% increase from HKD 34.0 trillion in the same period last year, indicating a rapid recovery in market valuations and a notable improvement in investor sentiment [1]. Trading Volume - The average daily trading volume in November was HKD 230.7 billion, representing a 43% year-on-year increase. For the first 11 months of the year, the average daily trading volume was HKD 255.8 billion, a substantial 95% increase, highlighting significant improvements in market liquidity [3]. IPO Market Performance - In the first 11 months of 2025, Hong Kong saw 93 new listings, a 52% increase from 61 in the same period last year. The total funds raised through IPOs reached HKD 575 billion, a remarkable 230% year-on-year increase, positioning Hong Kong among the top global exchanges for both the number of listings and fundraising [3][10][11]. Future Outlook - The strong IPO momentum is driven by three main factors: the recovery of global new economy enterprises, the ongoing trend of mainland companies seeking secondary listings in Hong Kong, and the influx of southbound capital providing support for the market. The outlook for the IPO market in 2026 is optimistic, with expectations of new peaks driven by sectors like AI, technology, and innovative pharmaceuticals [14][15].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to experience verifiable growth, leading to a potential revaluation [1] - The current price-to-earnings (PE) ratio is 38 times, with an upward potential of 24% based on a target PE of 42 times, resulting in a reasonable market value of 692 billion HKD [6][7] - The company benefits from its monopoly status and integrated clearing platform, which allows it to earn commissions from Average Daily Turnover (ADT) [6][7] Financial Data and Earnings Forecast - Revenue projections (in million HKD) for the years 2023 to 2027 are as follows: - 2023: 20,516 (11% growth) - 2024: 22,374 (9% growth) - 2025E: 26,978 (21% growth) - 2026E: 29,020 (8% growth) - 2027E: 29,857 (3% growth) [4] - Net profit attributable to shareholders (in million HKD) is forecasted as: - 2023: 11,862 (18% growth) - 2024: 13,050 (10% growth) - 2025E: 16,477 (26% growth) - 2026E: 17,936 (9% growth) - 2027E: 18,775 (5% growth) [4] - Earnings per share (in HKD) are projected to be: - 2023: 9.36 - 2024: 10.29 - 2025E: 13.00 - 2026E: 14.15 - 2027E: 14.81 [4] Valuation Review - The valuation range for the company is estimated between 30 to 70 times PE, with fundamental and liquidity factors being the core drivers [6][19] - The report emphasizes that the company’s growth potential is supported by the increasing market capitalization of new economy sectors, which have risen from 17% in 2018 to 35% in 2025 YTD [6][59] - The report highlights that the ADT is a critical factor influencing the company's profitability, with expectations for ADT to remain robust due to increased connectivity between mainland China and Hong Kong [6][8]